银杏叶滴丸联合缬沙坦胶囊治疗老年高血压患者的效果观察

doi:10.3760/cma.j.issn.1007-1245.2023.12.011

国际医药卫生导报 ›› 2023, Vol. 29 ›› Issue (12): 1674-1677.DOI: 10.3760/cma.j.issn.1007-1245.2023.12.011

银杏叶滴丸联合缬沙坦胶囊治疗老年高血压患者的效果观察

刘宁¹ 郑学燕² 董敏³ 孙宝莲⁴

¹济南市第二人民医院全科门诊，济南　250001；²济南市第二人民医院药学部，济南　250001；³济南市第二人民医院内科，济南　250001；⁴济南重汽医院内科，济南　250031

收稿日期:2023-01-13 出版日期:2023-06-15 发布日期:2023-06-26
通讯作者: 刘宁，Email：liuning5785@163.com
基金资助:
山东省自然科学基金（ZR2019MH064）

Effect of ginkgo biloba dropping pills combined with valsartan capsules in treatment of elderly patients with hypertension

Liu Ning¹, Zheng Xueyan², Dong Min³, Sun Baolian⁴

¹Clinic, Department of General Medicine, Jinan Second People's Hospital, Jinan 250001, China; ²Department of Pharmacy, Jinan Second People's Hospital, Jinan 250001, China; ³Department of Internal Medicine, Jinan Second People's Hospital, Jinan 250001, China; ⁴Department of Internal Medicine, Jinan Zhongqi Hospital, Jinan 250031, China

Received:2023-01-13 Online:2023-06-15 Published:2023-06-26
Contact: Liu Ning, Email: liuning5785@163.com
Supported by:
Shandong Natural Science Fund (ZR2019MH064)

摘要/Abstract

摘要：

目的　观察银杏叶滴丸联合缬沙坦胶囊治疗老年高血压患者的效果。方法　选取2020年1月至2021年12月济南市第二人民医院收治的老年高血压患者116例进行随机对照试验，采用随机数字表法将其分为联合治疗组和基础治疗组，各58例。基础治疗组男38例，女20例，年龄（70.23±3.51）岁。联合治疗组男39例，女19例，年龄（70.92±3.67）岁。基础治疗组采用银杏叶滴丸治疗，联合治疗组采用银杏叶滴丸联合缬沙坦胶囊治疗。对比两组患者治疗前后血压、临床疗效、治疗期间不良反应发生率。采用t检验、Z检验和χ²检验。结果　两组治疗后舒张压和收缩压均低于治疗前（均P<0.05）；治疗后，联合治疗组舒张压和收缩压均低于基础治疗组（均P<0.05）。联合治疗组总有效率为96.55%（56/58），明显高于基础治疗组的72.41%（42/58）（P<0.05）。联合治疗组治疗期间不良反应发生率与基础治疗组比较，差异无统计学意义（P>0.05）。结论　银杏叶滴丸联合缬沙坦胶囊治疗老年高血压能够有效提高临床疗效，且能够降低患者舒张压、收缩压，且具有安全性，值得推广使用。

关键词:

老年高血压, 银杏叶滴丸, 缬沙坦胶囊, 临床疗效, 舒张压, 收缩压

Abstract:

Objective　To observe the effect of ginkgo biloba dropping pills combined with valsartan capsules in the treatment of elderly patients with hypertension. Methods　A total of 116 elderly patients with hypertension admitted to Jinan Second People's Hospital from January 2020 to December 2021 were selected for the randomized controlled trial. The patients were divided into a combined treatment group and a basic treatment group by the random number table method, with 58 cases in each group. There were 38 males and 20 females in the basic treatment group; they were (70.23±3.51) years old. There were 39 males and 19 females in the combined treatment group; they were (70.92±3.67) years old. The basic treatment group were treated with ginkgo biloba dropping pills, and the combined treatment group with ginkgo biloba dropping pills and valsartan capsules. The blood pressures before and after the treatment, clinical efficacies, and incidences of adverse reactions during the treatment were compared between the two groups. t, Z, and χ² tests were applied. Results　The diastolic blood pressures and systolic blood pressures in the 2 groups were lower after than before the treatment (all P<0.05); after the treatment, the diastolic blood pressure and systolic blood pressure in the combined treatment group were lower than those in the basic treatment group (both P<0.05). The total effective rate of the combined treatment group was significantly higher than that of the basic treatment group [96.55% (56/58) vs. 72.41% (42/58); P<0.05]. There was no statistical difference in the incidence of adverse reactions during the treatment between the combined treatment group and the basic treatment group (P>0.05). Conclusion　Ginkgo biloba dripping pills combined with valsartan capsules in the treatment of elderly patients with hypertension can effectively improve the clinical efficacy and reduce their diastolic and systolic blood pressures, and is safe, so it is worthy of promotion.

Key words:

Hypertension in the elderly, Ginkgo biloba dropping pills, Valsartan capsules, Clinical efficacy, Diastolic blood pressure, Systolic blood pressure

刘宁郑学燕董敏孙宝莲.

银杏叶滴丸联合缬沙坦胶囊治疗老年高血压患者的效果观察 [J]. 国际医药卫生导报, 2023, 29(12): 1674-1677.

Liu Ning, Zheng Xueyan, Dong Min, Sun Baolian.

Effect of ginkgo biloba dropping pills combined with valsartan capsules in treatment of elderly patients with hypertension [J]. International Medicine and Health Guidance News, 2023, 29(12): 1674-1677.

参考文献

[1] 张岩,李娜. 复方杜仲胶囊联合贝那普利治疗老年高血压的临床研究[J]. 现代药物与临床,2023,38(1):96-100. DOI:10.7501/j.issn.1674-5515.2023.01.014.
[2] 齐红芳. 苯磺酸左旋氨氯地平治疗老年高血压的临床价值探究[J]. 中国实用医药,2022,17(27):162-164. DOI:10.14163/j.cnki.11-5547/r.2022.27.045.
[3] 何秋亮. 马来酸左旋氨氯地平治疗老年高血压的临床疗效[J]. 现代养生(上半月版),2022,22(12):2005-2006. DOI:10.3969/j.issn.1671-0223(s).2022.12.003.
[4] 陈晓琪. 阿托伐他汀钙联合氯沙坦治疗老年高血压患者的效果[J]. 中国民康医学,2022,34(22):36-39. DOI:10.3969/j.issn.1672-0369.2022.22.012.
[5] 韩亚辉. 缬沙坦氨氯地平片治疗老年高血压患者的临床效果[J]. 临床医学研究与实践,2022,7(33):59-61. DOI:10.19347/j.cnki.2096-1413.202233015.
[6] Henderson I, Quenby S. Gestational hypertension and childhood atopy: a Millennium Cohort Study analysis [J]. Eur J Pediatr, 2021, 180(8):2419-2427. DOI: 10.1007/s00431-021-04012-3.
[7] 华小黎,赵瑛,伍三兰,等. 缬沙坦与卡托普利治疗原发性高血压和慢性心力衰竭临床疗效比较的Meta分析[J]. 中国药师,2016,19(1):84-88,99. DOI:10.3969/j.issn.1008- 049X. 2016.01.024.
[8] 赵明娟,马琳璐,李柄辉,等. 银杏叶滴丸联合降压药治疗原发性高血压有效性的系统评价与Meta分析[J]. 中国循证心血管医学杂志,2019,11(8):910-913,918. DOI:10.3969/j.issn.1674-4055.2019.08.04.
[9] 赵金艳,崔少楠,曹月娟. 沙库巴曲缬沙坦钠治疗老年高血压慢性心力衰竭的疗效观察[J]. 中华老年心脑血管病杂志,2021,23(12):1268-1271. DOI:10.3969/j.issn.1009-0126. 2021.12.010.
[10] 杨孜, 张为远. 老年高血压疾病诊治指南(2015)[J]. 中华妇产科杂志, 2015(10):8.
[11] 李三喜,邢增文,赵涛,等. 参麦注射液联合尼莫地平对妊娠期高血压患者的临床疗效[J]. 中成药,2019,41(8):1839-1843. DOI:10.3969/j.issn.1001-1528.2019.08.017.
[12] Slivnick J, Lampert BC. Hypertension and heart failure [J]. Heart Fail Clin, 2019, 15(4):531-541. DOI: 10.1016/j.hfc.2019.06.007.
[13] Adler J, Gerhardt F, Wissmüller M, et al. Pulmonary hypertension associated with left-sided heart failure [J]. Curr Opin Cardiol, 2020, 35(6):610-619. DOI: 10.1097/HCO.0000000000000791.
[14] Sorrentino MJ. The evolution from hypertension to heart failure [J]. Heart Fail Clin, 2019, 15(4):447-453. DOI: 10.1016/j.hfc.2019.06.005.
[15] 方锐波,王春鹏,黄金娥.银杏叶滴丸联合氨氯地平对原发性高血压患者内皮功能和血脂及血压的影响[J].临床合理用药杂志,2019,12(3):30-32. DOI: 10.15887/j.cnki. 13-1389/r.2019.03.014.
[16] 杨坤,闫明,肖露露. 银杏叶滴丸与复方丹参滴丸治疗高血压患者的临床疗效分析[J]. 世界最新医学信息文摘,2017(96). DOI:10.19613/j.cnki.1671-3141.2017.96.093.
[17] 本木措,王峰,倪黎,等. 小剂量沙库巴曲缬沙坦与培哚普利治疗射血分数降低慢性心力衰竭的疗效与安全性对比研究[J]. 中国实用内科杂志,2021,41(6):526-530. DOI:10.19538/j.nk2021060116.
[18] 刘远胜,周华,刘中文,等. 低剂量沙库巴曲缬沙坦治疗老年射血分数降低型慢性心力衰竭的效果及安全性[J]. 中国当代医药,2022,29(16):20-24. DOI:10.3969/j.issn.1674- 4721. 2022.16.006.
[19] 李艳琴,王佳乐,张志宇. 缬沙坦胶囊联合苯磺酸氨氯地平治疗社区老年原发高血压合并糖尿病研究[J]. 医学食疗与健康,2022,20(3):80-82.

银杏叶滴丸联合缬沙坦胶囊治疗老年高血压患者的效果观察

Effect of ginkgo biloba dropping pills combined with valsartan capsules in treatment of elderly patients with hypertension

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 7

编辑推荐

Metrics

[1]	温诗瑜温炬冯颖君李慕锦秦思. 生物制剂在银屑病中的临床应用 [J]. 国际医药卫生导报, 2023, 29(9): 1185-1188.
[2]	徐丽琴, 洪庆荣, 方圆. 曲普瑞林对特发性中枢性性早熟女童的临床疗效和对骨龄的影响[J]. 国际医药卫生导报, 2022, 28(6): 829-832.
[3]	郭智华, 鲁培, 卢晓燕, 黄淑妍, 陈兴. 三七总皂甙对老年不稳定型心绞痛患者Th1/Th2细胞功能失衡的影响[J]. 国际医药卫生导报, 2022, 28(4): 532-536.
[4]	赵旭生, 姜涛, 李磊. 沙美特罗替卡松吸入剂联合布地奈德治疗哮喘的疗效[J]. 国际医药卫生导报, 2022, 28(12): 1724-1727.
[5]	李红军. 不同时期肺表面活性物质联合NCPAP治疗NRDS的临床疗效及安全性分析[J]. 国际医药卫生导报, 2022, 28(10): 1414-1417.
[6]	车启富, 何丽杰, 沈忠达. 芪莲花解毒丸联合中药膏敷贴治疗肺炎患者的效果分析[J]. 国际医药卫生导报, 2022, 28(10): 1422-1426.
[7]	杨晓娟, 徐蕾, 王丽华. 中医推拿对小儿支气管哮喘患者PEF以及C-ACT评分的影响分析[J]. 国际医药卫生导报, 2021, 27(6): 844-847.